LMPRC 2025

The LMP Research Conference (LMPRC) 2025

Abstract submissions are now closed (but registration is still open)

Please contact your program administrator or the organizing committee at lmp.rc@utoronto.ca if you have any questions.

A day where we celebrate and share the research conducted in the Department of Laboratory Medicine and Pathobiology.

The day will consist of:

  • Graduate student poster presentations

  • Postgraduate research poster presentations

  • Winning LMP 3-minute thesis competition presentation from Melissa Suma, MSc

  • Keynote speaker Dr. Michael Laflamme

  • Workshops on skills and techniques

  • Lots of networking

When and where

Thursday, April 17, 2025 all day

The Arcadian,
401 Bay Street, Simpson Tower 8th floor, Toronto, ON M5H 2Y4

How to register

Register now

If you have any questions, contact us at lmp.rc@utoronto.ca.

Important dates

  • 19 February, 2025 at 11:59 pm: abstract submissions close
  • 20 March, 2025 (approx): oral presenters will be announced
  • 1 April, 2025: registration closes

Information for attendees

Information for graduate students and postgraduate trainees: abstract submissions - now closed

Michael Laflamme

Keynote speaker: Dr. Michael Laflamme

Talk title: Heart regeneration with pluripotent stem cells

Dr. Michael Laflamme is the Robert McEwen Chair in Cardiac Regenerative Medicine, Canada Research Chair (Tier 1) in Cardiovascular Regenerative Medicine, Senior Scientist in the McEwen Stem Cell Institute, Staff Pathologist in the Laboratory Medicine Program at the University Health Network (UHN), and Professor of Laboratory Medicine & Pathobiology at the University of Toronto.

He leads a research program that is focused on developing novel cardiac cell therapies based on human pluripotent stem cells (hPSCs), and his laboratory has made a number of important contributions in this area including efficient protocols to guide hPSCs into cardiomyocytes, proof-of-concept transplantation studies with hPSC-derived cardiomyocytes in preclinical models, and the first direct demonstration that hPSC-derived cardiomyocytes can become electrically integrated and activate synchronously with host myocardium in injured hearts.

Dr. Laflamme has been the recipient of honors including the Society for Cardiovascular Pathology Young Investigator Award, the American Society of Gene & Cell Therapy Outstanding New Investigator Award, and the UHN Inventor of the Year.

He also practices cardiovascular and autopsy pathology and is a founding investigator of BlueRock Therapeutics. Read more in A 20 year path to translation: repairing broken hearts.

Find out what happened at the LMPRC 2024

See who won awards!
A group of people pointing at a poster